1. Home
  2. ALMS vs CLW Comparison

ALMS vs CLW Comparison

Compare ALMS & CLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALMS
  • CLW
  • Stock Information
  • Founded
  • ALMS 2021
  • CLW 2005
  • Country
  • ALMS United States
  • CLW United States
  • Employees
  • ALMS N/A
  • CLW N/A
  • Industry
  • ALMS
  • CLW Paper
  • Sector
  • ALMS
  • CLW Basic Materials
  • Exchange
  • ALMS NYSE
  • CLW Nasdaq
  • Market Cap
  • ALMS 469.0M
  • CLW 501.0M
  • IPO Year
  • ALMS 2024
  • CLW N/A
  • Fundamental
  • Price
  • ALMS $7.41
  • CLW $31.02
  • Analyst Decision
  • ALMS Strong Buy
  • CLW Buy
  • Analyst Count
  • ALMS 6
  • CLW 1
  • Target Price
  • ALMS $29.60
  • CLW $37.00
  • AVG Volume (30 Days)
  • ALMS 121.0K
  • CLW 534.1K
  • Earning Date
  • ALMS 02-15-2025
  • CLW 02-18-2025
  • Dividend Yield
  • ALMS N/A
  • CLW N/A
  • EPS Growth
  • ALMS N/A
  • CLW N/A
  • EPS
  • ALMS N/A
  • CLW 0.88
  • Revenue
  • ALMS N/A
  • CLW $2,211,900,000.00
  • Revenue This Year
  • ALMS N/A
  • CLW N/A
  • Revenue Next Year
  • ALMS N/A
  • CLW N/A
  • P/E Ratio
  • ALMS N/A
  • CLW $257.11
  • Revenue Growth
  • ALMS N/A
  • CLW 58.65
  • 52 Week Low
  • ALMS $6.75
  • CLW $23.97
  • 52 Week High
  • ALMS $13.53
  • CLW $57.13
  • Technical
  • Relative Strength Index (RSI)
  • ALMS N/A
  • CLW 62.69
  • Support Level
  • ALMS N/A
  • CLW $28.11
  • Resistance Level
  • ALMS N/A
  • CLW $30.71
  • Average True Range (ATR)
  • ALMS 0.00
  • CLW 1.22
  • MACD
  • ALMS 0.00
  • CLW 0.06
  • Stochastic Oscillator
  • ALMS 0.00
  • CLW 89.80

About ALMS ALUMIS INC

Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.

About CLW Clearwater Paper Corporation

Clearwater Paper Corp is engaged in the manufacturing and selling of private label tissue, paperboard, and pulp-based products. The company has two reportable segments namely the consumer products segment which manufactures and sells a complete line of at-home tissue products as well as AFH products. The pulp and paperboard segment manufactures and markets bleached paperboard for the high-end segment of the packaging industry as well as offers services that include custom sheeting, slitting and cutting of paperboard. It generates maximum revenue from Pulp and Paperboard segment. Geographically, it derives maximum revenue from the United States.

Share on Social Networks: